SwRI's Virtual Screening Software Rhodium Increases Processing Power for Coronavirus Research
February 20, 2020
February 20, 2020
SAN ANTONIO, Texas, Feb. 20 -- Southwest Research Institute issued the following news release:
Drug discovery software at Southwest Research Institute is expanding the capacity to virtually screen drug compounds for possible treatment of coronavirus and other infectious diseases.
SwRI's Rhodium(TM) virtual screening tool recently evaluated 2 million drug compounds in a few days, hoping to identify high-probability drugs that may have efficacy against the coronavirus wit . . .
Drug discovery software at Southwest Research Institute is expanding the capacity to virtually screen drug compounds for possible treatment of coronavirus and other infectious diseases.
SwRI's Rhodium(TM) virtual screening tool recently evaluated 2 million drug compounds in a few days, hoping to identify high-probability drugs that may have efficacy against the coronavirus wit . . .